HealthTech Nexus is the strategic partnership between Radboud University Medical Centre (Radboudumc) and the University of Twente that is at the interface of medical technology and healthcare. Together with partners, we work on knowledge development, education and innovation to meet unmet need in health and healthcare: urgent needs for which there are as yet no good solutions. From there, we work with patients, businesses and governments to translate this knowledge and innovation into new products and services for healthcare and health with a common goal: future-proofing healthcare through technological excellence.
Healthcare is under pressure worldwide. The demand for healthcare is constantly increasing due to social and demographic developments. At the same time, the number of treatment options is growing. This is resulting in staff shortages, increasing complexity and rapidly growing costs. Many of these issues are at the interface of healthcare and advanced technology; two domains that are becoming increasingly interconnected. Thanks to our unique and complementary expertise, together we can find new answers to these issues.
The preclinical facilities and simulation approach at the University of Twente fit perfectly with the clinical facilities and expertise of Radboudumc. Radboudumc’s hybrid operating theatres (MITeC) and the simulation labs of the University of Twente are examples of how a high-quality learning and development environment is created for the entire healthcare innovation process, from scientific idea to practical implementation. Within this environment, we combine our experience in fields such as AI, robotics, motion control, microtechnology and nanotechnology to develop new applications for medical imaging, interventional oncology and other care domains where technology can make a difference. At the same time, we are training a new generation of healthcare professionals who excel at developing and using modern technology to improve care and patient comfort.
At the TechMed Centre, we understand that the intersection of technology and medicine is where groundbreaking discoveries and life-changing innovations emerge. Our state-of-the-art TechMed Centre is at the forefront of the revolution.
An overview of all facilities is available on the TechMed Centre facilities page. Examples include:
Would you like more information about the possibilities (and availability) of the facilities at the TechMed Centre? Please contact Sebastiaan Waanders (department head TechMed Infra) using the details below.
Our mission is to have a significant impact on health and healthcare. This requires that we innovate and pioneer in a person-centred way, by working together in our networks, and by entering into strategic partnerships.
Most research facilities are organised into the Radboudumc Technology Centers. Examples include:
Would you like more information about the possibilities (and availability) of the facilities at Radboudumc? Please contact Nicolai Giling using the details below.
There are currently no events.
Each year, the University of Twente and Radboudumc jointly award four TURBO grants of €80K, aimed at new research collaborations between the two institutions. The grants support projects that match unmet clinical needs with technological solutions, such as new diagnostic methods and innovative therapies for diseases that are currently difficult to diagnose or treat. The goal is to prepare a joint grant application for substantial external funding, for example from national or EU funds, or from companies active in health and technology.
In 2027, a new TURBO Call for proposals will be published. Employees of the University of Twente and Radboudumc can once again participate in this joint grant initiative. The timeline, formats and all information will be updated below when the call opens, expected in April 2027.
The TURBO projects should align with the ambition to match unmet clinical needs with technological solutions, aiming to improve health and healthcare through the development of new diagnostic methods and innovative therapies for diseases that are currently difficult to diagnose or treat effectively. Opportunities for improvement include developing and applying emerging technologies—such as organ-on-a-chip systems, artificial intelligence and machine learning for the analysis of large amounts of data, e-health innovations, and sensing technologies, while also addressing legal, ethical, safety, financial, and practical considerations essential for the implementation of medical technology. Promising areas include the current opportunities in defence and healthcare applications, productivity-enhancing healthcare innovations, more sustainable medical materials, and advanced platforms like digital twins. The TURBO program also welcomes any emerging technologies that help meet unmet clinical needs. While TURBO projects can span a wide range of fields, the primary goal of a TURBO-assisted grant application should be to bring the application one step closer to the market or practical application. This means that the projects should preferably focus on a transition of Technology Readiness Level (TRL) or Societal Readiness Level (SRL).
Each year, the UT and Radboudumc jointly award four TURBO grants of 80K€. These project-based grants will be awarded to four new collaborations between researchers from the University of Twente and Radboudumc. New collaborations are defined as: A. No joint publications in the last 10 years. Additionally, researchers with dual appointments should start collaborations with researchers from other research groups. Resubmissions of previously rejected applications are allowed; in this case, applicants may have started working together. This pre-seed subsidy should support a joint grant application by a researcher of the University of Twente and a colleague of the Radboudumc. Typically, this concerns a collaborative grant application for the EU, NWO (e.g. TTW-grants), NWA routes, EFRO, Interreg, etc. Personal grants are explicitly excluded from this list. The grants can be spent freely, with an emphasis on generating sufficient background for the new grant application. The grants can, for example, be used to hire (new) scientific personnel, purchase equipment, arrange networking events for the set-up of new consortia, or realise participation of industrial parties/companies for a joint grant application.
Every proposal is first evaluated to fulfil the general eligibility criteria. Proposals that do not fulfil these general criteria will not be taken into consideration by this evaluation committee. The proposals are evaluated by at least two independent scientific experts (reviewers) and a grant advisor from each institution according to the criteria: (scientific) quality (50%), feasibility of the project and likelihood of obtaining additional funding (20%), innovativeness (15%) and (societal) impact (15%). The combined scores of both institutions are the basis for a final ranking by the evaluation committee. The evaluation committee must come to a unanimous agreement. If no consensus can be reached, the chairperson will make the final decision.
14 April 2026
TURBO2027 Call open
6 July 2026, 11.00
Deadline TURBO2027 Call
6 July – Sep 2026
Proposals evaluated by reviewers and the committee
1 October 2026
TURBO Granting meeting, TechMed Centre, Enschede
Not later than 1 Jan 2027
Start of projects
31 December 2027
End of projects, draft grant proposal written
1 April 2028
Final report submitted
Ultimatley 2028
Submitted grant application at external funding body
For general information or questions about the TURBO program:
If you have a question about HealthTech Nexus, please contact Remke Burie, the contact person on behalf of the University of Twente - TechMed Centre.